Initial and recurrent hyperkalemia events in patients with CKD in older adults: A population-based cohort study
Phase 1 Trials In a first-in-human, randomized, placebo-controlled, single ascending dose, phase 1 trial in healthy participants, retatrutide demonstrated a favourable safety profile (similar to other incretin-based therapies) and early signs of efficacy with dose-dependent WL [42]
The study indicated favorable binding with apoptotic protein receptors 1GJH, 1TUP, and 2XYG, suggesting a potential binding affinity between SGLT2 inhibitors and these receptors (Figure 3 (Figure 3)
In December 2024, the TRIUMPH-4 Phase 3 trial results were announced, showing that participants taking retatrutide 12 mg achieved an average weight loss of 71.8 pounds or 28.7% of body weight over 68 weeks
The surgery involves an incision running from the armpit to the elbow along the inner arm, allowing removal of both excess skin and fat
But if you are taking a glucagon-like peptide-1 drug better known as GLP-1 for weight loss, the protocol for getting back on track may be different from missing a dose of antibiotics
